Brookfield Asset Management Inc. Idexx Laboratories Inc Transaction History

Brookfield Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Sep 25, 2023	BUY	$406.01 - $514.59 $15.2 Million - $19.2 Million	37,393 New	37,393 $18.7 Million
Q1 2023 May 15, 2023	BUY	$406.01 - $514.59 $11.2 Million - $14.2 Million	27,651 Added 283.83%	37,393 $18.7 Million
Q4 2022 Feb 14, 2023	BUY	$324.64 - $441.27 $2.3 Million - $3.12 Million	7,074 Added 265.14%	9,742 $3.97 Million
Q3 2022 Nov 14, 2022	SELL	$325.8 - $407.78 $2.79 Million - $3.49 Million	-8,567 Reduced 76.25%	2,668 $869,000
Q2 2022 Nov 16, 2022	BUY	$327.37 - $553.44 $2.8 Million - $4.74 Million	8,567 Added 321.1%	11,235 $3.94 Million
Q2 2022 Aug 15, 2022	BUY	$327.37 - $553.44 $3.13 Million - $5.3 Million	9,576 Added 577.22%	11,235 $3.94 Million
Q4 2020 Feb 16, 2021	BUY	$383.85 - $499.87 $636,807 - $829,284	1,659 New	1,659 $829,000

1,212

72.5M

167K

343K

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $34.3B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.